Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,226,022 papers from all fields of science
Search
Sign In
Create Free Account
0.6 ML Fondaparinux sodium 12.5 MG/ML Prefilled Syringe [Arixtra]
Known as:
FONDAPARINUX SODIUM 7.5 mg in 0.6 mL SUBCUTANEOUS INJECTION, SOLUTION [ARIXTRA]
, 0.6 ML Arixtra 12.5 MG/ML Prefilled Syringe
, Arixtra 7.5 MG in 0.6 ML Prefilled Syringe
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
Arixtra
Fondaparinux sodium
Prefilled Syringe
Sodium Chloride
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2021
Review
2021
Fondaparinux Sodium
S. Blick
,
Jennifer S. Orman
,
A. Wagstaff
,
L. Scott
Reactions weekly
2021
Corpus ID: 10711917
SummaryAbstractFondaparinux sodium (Arixtra®) is a synthetic, sulfated pentasaccharide, selective factor Xa inhibitor that is…
Expand
2019
2019
Advancing MSn spatial resolution and documentation for glycosaminoglycans by sulfate-isotope exchange
Qing Guo
,
V. Reinhold
Analytical and Bioanalytical Chemistry
2019
Corpus ID: 172136304
Glycosaminoglycans (GAGs) are carbohydrate polyionic polymers that participate in a host of critically important biological…
Expand
2019
2019
Evaluating heparin products for heparin-induced thrombocytopenia using surface plasmon resonance.
Fuming Zhang
,
Payel Datta
,
J. Dordick
,
R. Linhardt
Journal of Pharmacy and Science
2019
Corpus ID: 207961399
2015
2015
Investigating changes in the gas-phase conformation of Antithrombin III upon binding of Arixtra using traveling wave ion mobility spectrometry (TWIMS).
Yuejie Zhao
,
Arunima Singh
,
+5 authors
I. Amster
In Analysis
2015
Corpus ID: 8111164
We validate the utility of ion mobility to measure protein conformational changes induced by the binding of glycosaminoglycan…
Expand
2012
2012
A closer look at the nitrogen next door: 1H-15N NMR methods for glycosaminoglycan structural characterization.
Derek J. Langeslay
,
S. Béni
,
C. Larive
Journal of magnetic resonance (San Diego, Calif…
2012
Corpus ID: 30643914
2012
2012
Fondaparinux Sodium
Neil A. Reynolds
,
C. Perry
,
L. Scott
Drugs
2012
Corpus ID: 46986991
SummaryAbstractFondaparinux sodium (Arixtra®; fondaparinux) is the first of a new class of synthetic pentasaccharide…
Expand
2009
2009
An Ion Mobility-Mass Spectrometry Investigation of Monocyte Chemoattractant Protein-1.
Matthew R. Schenauer
,
J. Leary
International Journal of Mass Spectrometry
2009
Corpus ID: 44743548
2004
2004
Le pentasaccharide (fondaparinux sodium, Arixtra ® ) : avantage à la synthèse ?
R. Cariou
2004
Corpus ID: 70611361
Auteur(s) :, Roger Cariou* Departement therapeutique thrombose, Sanofi Synthelabo Recherche, 91385 Chilly Mazarin cedex, France…
Expand
2004
2004
Initial Outpatient Treatment of Venous Thromboembolism with Fondaparinux (Arixtra®): The Matisse Trials.
H. Büller
2004
Corpus ID: 78342624
Background: The MATISSE trials showed that a single dose regimen of fondaparinux, a synthetic selective factor Xa inhibitor, was…
Expand
2002
2002
Fondaparinux (Arixtra), a new anticoagulant.
P. Giangrande
The Medical letter on drugs and therapeutics
2002
Corpus ID: 2714295
Fondaparinux is a promising new antithrombotic agent. This pentasaccharide selectively and specifically inhibits coagulation…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE